Ani Pharmaceuticals (ANIP) Exchange Rate Effect (2024 - 2026)
Ani Pharmaceuticals' (ANIP) quarterly Exchange Rate Effect came in at $67000.0 in Q2 2026, down 92.03% year-over-year from $841000.0 in Q2 2025, and down 57.05% quarter-over-quarter from $156000.0 in Q1 2026.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Ani Pharmaceuticals has disclosed Exchange Rate Effect across 3 years of filings, most recently posting $67000.0 for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 92.03% year-over-year to $67000.0; the TTM figure through Jun 2026 stood at -$554000.0 (down 848.65% YoY), while the FY2025 annual figure was -$233000.0, up 50.43% from the prior year.
- Exchange Rate Effect came in at $67000.0 for Q2 2026 at Ani Pharmaceuticals, down from $156000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $841000.0 in Q2 2025 to a low of -$1.4 million in Q4 2025.
- Average Exchange Rate Effect over 3 years is -$60000.0, with a median of -$4000.0 recorded in 2024.
- The largest YoY upside for Exchange Rate Effect was 868.0% in 2025 against a maximum downside of 242.53% in 2025.
- Over 3 years, Exchange Rate Effect stood at -$395000.0 in 2024, then slumped by 242.53% to -$1.4 million in 2025, then jumped by 104.95% to $67000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $67000.0 in Q2 2026, $156000.0 in Q1 2026, and -$1.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | -5.00 Mn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | -3.30 Mn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 411,947.57 |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | -164,000.00 |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | -2.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -2.13 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 67,000.00 |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 16,000.00 |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67,000.00 |
| Mar 31, 2026 | 156,000.00 |
| Dec 31, 2025 | -1.35 Mn |
| Sep 30, 2025 | 576,000.00 |
| Jun 30, 2025 | 841,000.00 |
| Mar 31, 2025 | -297,000.00 |
| Dec 31, 2024 | -395,000.00 |
| Sep 30, 2024 | -75,000.00 |